CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks
Summarize this article with:
Andrew HechtInvesting Group LeaderFollow5ShareSavePlay(7min)CommentsSummaryDirexion Daily Healthcare Bull 3X Shares ETF has surged 83.5% since August 2025, reflecting bullish momentum in healthcare and pharma sectors.Reduced regulatory uncertainty, successful clinical trials, M&A activity, and prospects for 2026 rate cuts underpin the bullish thesis for CURE.CURE's leveraged structure amplifies both gains and losses, with significant time decay and risk, making it suitable only for tactical trading.Effective risk management via strict price and time stops is essential when trading CURE, given its triple-leverage and potential for rapid capital erosion. Morsa Images/DigitalVision via Getty Images Healthcare is one of the leading issues facing the United States in late 2025. The recent government shutdown put healthcare and the Affordable Care Act in the spotlight. The gulf between Democrats and Republicans is vastThis article was written byAndrew Hecht30.67K FollowersFollowAndrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group The Hecht Commodity Report, one of the most comprehensive commodities services available. It covers the market movements of 20 different commodities and provides bullish, bearish and neutral calls; directional trading recommendations, and actionable ideas for traders. Learn more.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The author always has positions in commodities markets in futures, options, ETF/ETN products, and commodity equities. These long and short positions tend to change on an intraday basis.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Recommended For You